![]() | ![]() |
Formats:
|
||||||||||
Copyright © 2009 Vrolijk et al; licensee BioMed Central Ltd. Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation 1Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands Corresponding author.Martine M Vrolijk: m.m.vrolijk/at/gmail.com; Alex Harwig: a.harwig/at/amc.uva.nl; Ben Berkhout: b.berkhout/at/amc.uva.nl; Atze T Das: a.t.das/at/amc.uva.nl Received December 15, 2008; Accepted February 11, 2009. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background Two hairpin structures that are present at both the 5' and 3' end of the HIV-1 RNA genome have important functions in the viral life cycle. The TAR hairpin binds the viral Tat protein and is essential for Tat-mediated activation of transcription. The adjacent polyA hairpin encompasses the polyadenylation signal AAUAAA and is important for the regulation of polyadenylation. Specifically, this RNA structure represses polyadenylation at the 5' side, and enhancer elements on the 3' side overcome this suppression. We recently described that the replication of an HIV-1 variant that does not need TAR for transcription was severely impaired by destabilization of the TAR hairpin, even though a complete TAR deletion was acceptable. Results In this study, we show that the TAR-destabilizing mutations result in reduced 3' polyadenylation of the viral transcripts due to an extension of the adjacent polyA hairpin. Thus, although the TAR hairpin is not directly involved in polyadenylation, mutations in TAR can affect this process. Conclusion The stability of the HIV-1 TAR hairpin structure is important for the proper folding of the viral RNA transcripts. This study illustrates how mutations that are designed to study the function of a specific RNA structure can change the structural presentation of other RNA domains and thus affect viral replication in an indirect way. Background All retroviral RNA genomes contain a repeat (R) region at the extreme 5' and 3' end. This sequence repeat allows the first strand transfer step of the reverse transcription process, which results in the formation of long terminal repeat (LTR) regions in the proviral DNA. The 97-nt R region in HIV-1 RNA can fold two stem-loop structures, the TAR and polyA hairpins (Fig. (Fig.1A).1A
The polyA hairpin encompasses the AAUAAA polyadenylation signal that is recognized by the cleavage polyadenylation specificity factor (CPSF), resulting in polyadenylation of the viral transcripts. Whereas TAR should exert its function in the 5' LTR promoter context, the polyadenylation signal should be recognized exclusively in the 3' LTR context. Previous studies indicated that usage of the 3' polyadenylation site is promoted by an upstream sequence element (USE) in the U3 region that is uniquely present at the 3' end of viral transcripts [18-22]. This element enhances binding of CPSF to the AAUAAA motif [23]. The 5' polyadenylation site may also be inactive because it is positioned close to the transcription initiation site, such that polyadenylation factors have not yet gained access to the nascent transcript through the RNA polymerase II complex [24-26]. Moreover, binding of U1 snRNP to the major splice donor site that is uniquely present downstream of 5' R represses polyadenylation at the 5' polyadenylation signal [27,28]. We previously demonstrated that the polyA hairpin masks the AAUAAA signal from recognition by CPSF and that the stability of the polyA hairpin is delicately balanced to allow 5' repression and 3' activation of polyadenylation [29-31]. We recently used the designed HIV-rtTA variant that does not need TAR for activation of transcription (Fig. (Fig.1A1A Results HIV-rtTA expression is reduced by destabilization but not by truncation of the TAR hairpin We previously demonstrated that the TAR-destabilizing A and B mutations induce an alternative folding at the 5' end of the HIV-rtTA transcripts. Since TAR is part of the R region that is present at both ends of the viral RNA, the TAR deletions may also affect 3' RNA functions such as polyadenylation. We therefore analyzed the effect of the TAR deletions on viral gene expression, RNA production and processing. C33A cervix carcinoma cells were transfected with the HIV-rtTA molecular clones that contain either the original TARm hairpin or modified TAR sequences at both the 5' and 3' LTR. After culturing the cells with dox for two days, we quantified virus production by measuring the CA-p24 level in the culture medium (Fig. (Fig.2A).2A
Northern blot analysis of RNA isolated from transfected C33A cells revealed that the reduced viral protein production of the A and B mutants correlated with a reduced level of unspliced (9 kb), single spliced (4 kb) and double spliced (2 kb) HIV-rtTA transcripts, whereas normal amounts were observed for the AB mutant (Fig. (Fig.2C).2C Destabilization of the 3' TAR element hinders polyadenylation of viral transcripts To avoid inclusion of vector sequences in the viral RNAs, we made a novel set of HIV-rtTA constructs in which the SV40-derived polyadenylation signal is positioned downstream of the 3' LTR (Fig. (Fig.3A).3A
C33A cells were transfected with the new HIV-rtTA-SV40 constructs. After two days of culturing with dox, the original and all TAR-mutated HIV-rtTA-SV40 constructs showed no significant variation in the production of CA-p24 (Fig. (Fig.3B),3B To rule out aberrant splicing of the viral transcripts, we analyzed the splice pattern of the TAR-deleted HIV-rtTA-SV40 variants in more detail. The isolated cellular RNA was used for the synthesis of cDNA, which was PCR amplified with primer combinations that detect unspliced or spliced viral RNAs (Fig. (Fig.3E).3E Discussion We demonstrate that destabilization of the TAR hairpin in HIV-1 RNA results in reduced polyadenylation at the 3' end of the viral transcripts. Incomplete polyadenylation of the transcripts will result in read-through transcripts that contain vector or cellular genome sequences when proviral plasmids or integrated proviruses are transcribed, respectively. These improperly polyadenylated transcripts may be less stable and we did indeed observe reduced levels of viral RNA and protein (Fig. (Fig.2).2 We recently showed that destabilization of the 5' TAR element does affect the LDI-BMH equilibrium of the leader RNA [35]. Whereas in vitro produced wild-type and AB-mutated leader transcripts adopted predominantly the LDI conformation, the A and B mutants demonstrated a shift toward the alternative BMH conformation. Probing of the RNA structure showed that TAR destabilization liberates TAR-nucleotides that can pair with unpaired nucleotides downstream of the polyA hairpin to extend this structure [35]. This extension increases the thermodynamic stability (ΔG) of the polyA hairpin from -17.5 kcal/mole to -24.7 kcal/mole, as predicted by the Mfold program [39]. Stabilization of the 5' polyA hairpin, which is part of the BMH structure, did indirectly affect the LDI/BMH equilibrium and leader-mediated RNA dimerization. Stabilization of the 3' polyA hairpin explains the reduced polyadenylation of the 3'-TAR destabilized transcripts (A and B mutants), as we previously demonstrated that such an increase in the polyA hairpin stability hinders the binding of polyadenylation factors to the AAUAAA polyadenylation signal [40] and decreases the efficiency of polyadenylation [29-31]. It has previously been suggested that folding of the TAR hairpin is important to appropriately space the upstream sequence element (USE) and 3' polyadenylation site in the RNA transcript [20]. This would resemble the situation in the human T-cell leukemia virus type-I (HTLV-1), where folding of a 276-nt spacer functionally juxtaposes the AAUAAA sequence and the polyadenylation cleavage site [41]. The AB-mutation will result in a truncated but stable stem-loop structure that will not affect the spacing between the USE and polyadenylation site. RNA structure probing studies [35] indicated that the A and B mutants fold an alternative, significantly less stable stem-loop structure that may effectively increase the spacer and thus contribute to the reduced polyadenylation efficiency. Several studies suggested that the TAR hairpin has other functions in HIV-1 replication in addition to its role in transcription, such as in translation, dimerization, packaging and reverse transcription of the viral RNA [9-15,42-44] (and references therein). Most of these studies were complicated by the fact that mutations in TAR have a dominant negative effect on viral transcription, which obscures other effects in the viral life cycle. Using the HIV-rtTA variant that does not need TAR for the activation of transcription, we recently demonstrated that complete deletion of TAR does not abolish in vitro replication, which indicates that TAR has no other essential function in HIV-1 replication [34]. Moreover, our TAR deletion studies demonstrate that TAR destabilization is risky because it induces unwanted side effects. TAR opening triggers the formation of an extended and more stable polyA hairpin, which affects the structure and function of both the 5' leader and the 3' end of the viral RNA. These TAR mutations indirectly affect dimerization, packaging and polyadenylation of the viral transcripts, but TAR is not directly involved in these processes. Apparently, the wild-type TAR element is sufficiently stable to prevent the TAR-nucleotides from interacting with other RNA domains. Conclusion Although the TAR hairpin is not directly involved in polyadenylation of the HIV-1 RNA transcripts, destabilization of TAR does affect this process. This study demonstrates that the stability of TAR structure is important for proper folding of the adjacent polyA hairpin. Methods Construction of HIV-rtTA variants Construction of the infectious HIV-rtTA molecular clone and variants with a deletion in the 5' TAR or both the 5' and 3' TAR elements were described previously [32,34]. For the construction of the 3' TAR-mutated variants, the BamHI-BglI fragment of the constructs with both 5' and 3' deletions, which encodes the 3' half of the viral genome, was used to replace the corresponding fragment in HIV-rtTA. The SV40 polyadenylation signal was inserted downstream of the 3' LTR in these constructs as follows. We first made a pBlue-NANB cloning vector with NotI, AatII, NcoI and BamHI sites in the multiple cloning site. For this, the primers MCS-NANB-Fw (GGC CGC GAC GTC CAT GGT CTA GAT CTG GAT CCA CGT) and MCS-NANB-Rev (GGA TCC AGA TCT AGA CCA TGG ACG TCG C) were annealed and ligated into the NotI-AatII digested pBluescript fragment of pBue3'LTRext-ΔU3-rtTAF86Y A209T-2ΔtetO [32]. The NcoI-BamHI fragment of pGL3-basic (Promega) that encodes the firefly luciferase gene and SV40 polyadenylation site was ligated into the NcoI and BamHI sites of pBlue-NANB, resulting in the pBlue-MCS-luc-SV40pA plasmid. The luciferase gene was removed by digestion with NcoI and XbaI, blunting of the sticky ends with Klenow polymerase and self-ligation of the vector to produce pBlue-MCS-SV40pA. The AatII-BglI fragment of this plasmid, which contains the SV40 polyadenylation signal, was inserted into the AatII and BglI sites downstream of the 3' LTR in the different HIV-rtTA clones. Cell culturing HeLa X1/6 is a HeLa-derived cervix carcinoma cell line containing chromosomally integrated copies of the CMV-7tetO luciferase reporter construct pUHC13-3 [45]. HeLa X1/6 and C33A (ATCC HTB31) [46] were grown as a monolayer in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS and minimal essential medium nonessential amino acids, penicillin (100 U/ml) and streptomycin (100 μg/ml). All cell cultures were kept at 37°C and 5% CO2. Transient transfection and RNA isolation C33A cells were cultured in 10-cm2 wells, grown to 60% confluency and transfected with 5 μg HIV-rtTA construct by calcium phosphate precipitation as previously described [32]. Cells were cultured in the presence of 1 μg/ml doxycycline (dox) (Sigma D-9891) and the culture medium was changed after 16 h. The virus level in the culture medium was quantitated by CA-p24 enzyme-linked immunosorbent assay (ELISA) after two days [47]. The cells were subsequently washed with phosphate buffered saline (PBS), briefly incubated with 0.5 ml 0.05% trypsin-EDTA (Invitrogen) till cells detached from the plate and resuspended in 1 ml 10% fetal bovine serum-containing medium to inactivate trypsin. Cells were pelleted at 2,750 × g for 5 min, washed in 1 ml PBS, centrifuged at 2,750 × g for 5 min, resuspended in 0.6 ml RLT buffer (QIAGEN) and homogenized with a QIAshredder column (QIAGEN). Total RNA was isolated with the RNeasy kit (QIAGEN) procedure, and contaminating DNA was removed with RNase-free DNase (QIAGEN) that was added during the isolation procedure as described in the RNeasy protocol. Northern blot analysis Gel electrophoresis of RNA was performed on a 1% agarose gel in MOPS buffer (40 mM MOPS, 10 mM sodium acetate, pH 7.0) with 7% formaldehyde at 100 Volt. The RNA was transferred overnight onto a positively charged nylon membrane (Boehringer Mannheim) by means of capillary force. RNA was attached to the membrane with a UV crosslinker (Stratagene). The 373-bp EcoRV-HinDIII fragment of HIV-rtTA encoding the U3/R region was 32P-labeled with the High Prime DNA Labeling kit (Roche Diagnostics) and used as HIV-rtTA probe. To generate the SV40 probe, the HIV-rtTA-SV40 TARm molecular clone was digested with AatII and BamHI and the 276-bp fragment was isolated and labeled as described above. Prehybridization and hybridization was done in ULTRAhyb buffer (Ambion) at 55°C for 1 and 16 h, respectively. The membrane was then washed two times at room temperature for 5 min in low-stringency buffer (2 × SSC, 0.2% SDS) and two times for 10 min at 50°C in high stringency buffer (0.1 × SSC, 0.2% SDS). Images were obtained using the PhosphorImager (Amersham Biosciences) and data analysis was performed with the ImageQuant software package. The Northern blot was stripped by boiling the membrane at 70°C in 0.1% SDS for 3 times 1 h. The stripping efficiency was controlled by scintillation counting and the blot was hybridized with the SV40 probe after prehybridization. Splicing and polyadenylation assay To analyze splicing and polyadenylation of the viral transcripts, the isolated RNA was reverse transcribed with ThermoScript reverse transcriptase at 50°C (Invitrogen), using the oligo(dT)25 and random hexamers primers. The cDNA product was used as template in a polymerase chain reaction (PCR) with primers 1 (GAG ACC ATC AAT GAG GAA GCT GCA GAA TGG GA) and 2 (GGC CGG CCC TTG TAG GCC GGC CAG ATC TTC CC) to detect the unspliced RNAs, with primers 3 (TCA ATA AAG CTT GCC TTG AGT GC) and 4 (CTC CGC AGA TCG TCC CAG AT) to detect the single spliced RNAs, and with primers 3 and 5 (CTA TGA TTA CTA TGG ACC ACA CA) to detect the double spliced RNAs. The polyadenylated RNAs were detected with primer 6 (CTG TGT CAG CAA GGC TTC TC) and the 3'RACE adapter primer 7 (GGC CAC GCG TCG ACT AGT ACT TTT TTT TTT TTT TTT T) that anneals to the polyA tail. The cDNA was denatured at 94°C for 5 min and amplified in 35 cycles of 1 min 95°C, 1 min 55°C, 2 min 72°C and a final extension time of 7 min at 72°C. The PCR products were visualized on a 1% agarose gel stained with ethidium bromide. rtTA assay HeLa X1/6 cells were cultured in 2-cm2 wells to 60% confluency and transfected with 1 μg of the HIV-rtTA constructs and 0.5 ng pRL-CMV (Promega), in which the expression of Renilla luciferase is controlled by the CMV immediate-early enhancer promoter, to allow correction for differences in transfection efficiency. The cells were cultured with dox (1 μg/ml) and the medium was refreshed after 16 h. The culture medium was collected after 48 hours for CA-p24 measurement. The cells were washed with 1 ml PBS and subsequently lysed with passive lysis buffer (Promega). Firefly and Renilla luciferase activities were determined with the dual-luciferase assay (Promega). The rtTA level was calculated as the ratio between the firefly and Renilla luciferase activities and corrected for between session variation [48]. Competing interests The authors declare that they have no competing interests. Authors' contributions MMV and AH performed the experiments. MMV drafted the manuscript. ATD and BB designed the experiments and revised the manuscript. Acknowledgements We thank Stephan Heynen for performing CA-p24 ELISA. This research was sponsored by NWO-CW (Top grant) and the Dutch AIDS Foundation (AIDS Fonds grant 2005022). References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||
Retrovirology. 2007 May 30; 4():36.
[Retrovirology. 2007]Cell. 1998 Feb 20; 92(4):451-62.
[Cell. 1998]Proc Natl Acad Sci U S A. 1999 Jul 6; 96(14):7791-6.
[Proc Natl Acad Sci U S A. 1999]Nature. 1996 Nov 28; 384(6607):375-8.
[Nature. 1996]PLoS Biol. 2005 Feb; 3(2):e44.
[PLoS Biol. 2005]J Biol Chem. 2004 Apr 30; 279(18):18776-82.
[J Biol Chem. 2004]J Virol. 2001 Jan; 75(2):979-87.
[J Virol. 2001]J Virol. 2007 Jul; 81(14):7742-8.
[J Virol. 2007]Nucleic Acids Res. 2008 Aug; 36(13):4352-63.
[Nucleic Acids Res. 2008]J Virol. 1991 Jun; 65(6):3340-3.
[J Virol. 1991]Mol Cell Biol. 1992 Sep; 12(9):3699-705.
[Mol Cell Biol. 1992]Genes Dev. 1995 Jan 1; 9(1):72-83.
[Genes Dev. 1995]EMBO J. 1992 Apr; 11(4):1513-24.
[EMBO J. 1992]Nature. 1997 Jan 23; 385(6614):357-61.
[Nature. 1997]J Biol Chem. 2004 Apr 30; 279(18):18776-82.
[J Biol Chem. 2004]J Virol. 2001 Jan; 75(2):979-87.
[J Virol. 2001]J Virol. 2007 Jul; 81(14):7742-8.
[J Virol. 2007]Nucleic Acids Res. 2008 Aug; 36(13):4352-63.
[Nucleic Acids Res. 2008]RNA. 2001 Jan; 7(1):143-57.
[RNA. 2001]J Virol. 2007 Jul; 81(14):7742-8.
[J Virol. 2007]Nucleic Acids Res. 2008 Aug; 36(13):4352-63.
[Nucleic Acids Res. 2008]Nucleic Acids Res. 2003 Jul 1; 31(13):3406-15.
[Nucleic Acids Res. 2003]Nucleic Acids Res. 1999 Jan 15; 27(2):446-54.
[Nucleic Acids Res. 1999]J Virol. 1999 Jan; 73(1):81-91.
[J Virol. 1999]Nucleic Acids Res. 1998 Apr 15; 26(8):1870-6.
[Nucleic Acids Res. 1998]EMBO J. 1992 Dec; 11(12):4419-28.
[EMBO J. 1992]J Virol. 1991 Oct; 65(10):5165-73.
[J Virol. 1991]Nucleic Acids Res. 2008 Aug; 36(13):4352-63.
[Nucleic Acids Res. 2008]J Biol Chem. 2004 May 21; 279(21):22243-9.
[J Biol Chem. 2004]RNA. 2001 Aug; 7(8):1097-114.
[RNA. 2001]J Virol. 1999 Jan; 73(1):101-9.
[J Virol. 1999]J Virol. 2000 Jun; 74(12):5639-46.
[J Virol. 2000]J Virol. 2007 Jul; 81(14):7742-8.
[J Virol. 2007]J Biol Chem. 2004 Apr 30; 279(18):18776-82.
[J Biol Chem. 2004]J Virol. 2007 Jul; 81(14):7742-8.
[J Virol. 2007]Proc Natl Acad Sci U S A. 1992 Jun 15; 89(12):5547-51.
[Proc Natl Acad Sci U S A. 1992]J Natl Cancer Inst. 1964 Jan; 32():135-63.
[J Natl Cancer Inst. 1964]J Biol Chem. 2004 Apr 30; 279(18):18776-82.
[J Biol Chem. 2004]Retrovirology. 2006 Sep 27; 3():64.
[Retrovirology. 2006]Retrovirology. 2006 Jan 6; 3():1.
[Retrovirology. 2006]